Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension

A role for superoxide and peroxynitrite in the intact lamb

Peter Oishi, Albert Grobe, Eileen Benavidez, Boaz Ovadia, Cynthia Harmon, Gregory A. Ross, Karen Hendricks-Munoz, Jie Xu, Stephen M. Black, Jeffrey R. Fineman

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Previous in vivo studies indicate that inhaled nitric oxide (NO) decreases nitric oxide synthase (NOS) activity and that this decrease is associated with significant increases in pulmonary vascular resistance (PVR) upon the acute withdrawal of inhaled NO (rebound pulmonary hypertension). In vitro studies suggest that superoxide and peroxynitrite production during inhaled NO therapy may mediate these effects, but in vivo data are lacking. The objective of this study was to determine the role of superoxide in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy in vivo. In control lambs, 24 h of inhaled NO (40 ppm) decreased NOS activity by 40% (P < 0.05) and increased endothelin-1 levels by 64% (P < 0.05). Withdrawal of NO resulted in an acute increase in PVR (60.7%, P < 0.05). Associated with these changes, superoxide and peroxynitrite levels increased more than twofold (P < 0.05) following 24 h of inhaled NO therapy. However, in lambs treated with polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) during inhaled NO therapy, there was no change in NOS activity, no increase in superoxide or peroxynitrite levels, and no increase in PVR upon the withdrawal of inhaled NO. In addition, endothelial NOS nitration was 18-fold higher (P < 0.05) in control lambs than in PEG-SOD-treated lambs following 24 h of inhaled NO. These data suggest that superoxide and peroxynitrite participate in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy. Reactive oxygen species scavenging may be a useful therapeutic strategy to ameliorate alterations in endogenous NO signaling during inhaled NO therapy.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume290
Issue number2
DOIs
StatePublished - Feb 1 2006

Fingerprint

Peroxynitrous Acid
Pulmonary Hypertension
Nitric Oxide Synthase
Superoxides
Nitric Oxide
Vascular Resistance
Therapeutics
Nitric Oxide Synthase Type III
Endothelin-1
Reactive Oxygen Species

Keywords

  • Nitric oxide synthase
  • Reactive oxygen species
  • Rebound pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology

Cite this

Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension : A role for superoxide and peroxynitrite in the intact lamb. / Oishi, Peter; Grobe, Albert; Benavidez, Eileen; Ovadia, Boaz; Harmon, Cynthia; Ross, Gregory A.; Hendricks-Munoz, Karen; Xu, Jie; Black, Stephen M.; Fineman, Jeffrey R.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 290, No. 2, 01.02.2006.

Research output: Contribution to journalArticle

Oishi, Peter ; Grobe, Albert ; Benavidez, Eileen ; Ovadia, Boaz ; Harmon, Cynthia ; Ross, Gregory A. ; Hendricks-Munoz, Karen ; Xu, Jie ; Black, Stephen M. ; Fineman, Jeffrey R. / Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension : A role for superoxide and peroxynitrite in the intact lamb. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2006 ; Vol. 290, No. 2.
@article{0e534b29fb674ca8ae71a1705078622c,
title = "Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: A role for superoxide and peroxynitrite in the intact lamb",
abstract = "Previous in vivo studies indicate that inhaled nitric oxide (NO) decreases nitric oxide synthase (NOS) activity and that this decrease is associated with significant increases in pulmonary vascular resistance (PVR) upon the acute withdrawal of inhaled NO (rebound pulmonary hypertension). In vitro studies suggest that superoxide and peroxynitrite production during inhaled NO therapy may mediate these effects, but in vivo data are lacking. The objective of this study was to determine the role of superoxide in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy in vivo. In control lambs, 24 h of inhaled NO (40 ppm) decreased NOS activity by 40{\%} (P < 0.05) and increased endothelin-1 levels by 64{\%} (P < 0.05). Withdrawal of NO resulted in an acute increase in PVR (60.7{\%}, P < 0.05). Associated with these changes, superoxide and peroxynitrite levels increased more than twofold (P < 0.05) following 24 h of inhaled NO therapy. However, in lambs treated with polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) during inhaled NO therapy, there was no change in NOS activity, no increase in superoxide or peroxynitrite levels, and no increase in PVR upon the withdrawal of inhaled NO. In addition, endothelial NOS nitration was 18-fold higher (P < 0.05) in control lambs than in PEG-SOD-treated lambs following 24 h of inhaled NO. These data suggest that superoxide and peroxynitrite participate in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy. Reactive oxygen species scavenging may be a useful therapeutic strategy to ameliorate alterations in endogenous NO signaling during inhaled NO therapy.",
keywords = "Nitric oxide synthase, Reactive oxygen species, Rebound pulmonary hypertension",
author = "Peter Oishi and Albert Grobe and Eileen Benavidez and Boaz Ovadia and Cynthia Harmon and Ross, {Gregory A.} and Karen Hendricks-Munoz and Jie Xu and Black, {Stephen M.} and Fineman, {Jeffrey R.}",
year = "2006",
month = "2",
day = "1",
doi = "10.1152/ajplung.00019.2005",
language = "English (US)",
volume = "290",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension

T2 - A role for superoxide and peroxynitrite in the intact lamb

AU - Oishi, Peter

AU - Grobe, Albert

AU - Benavidez, Eileen

AU - Ovadia, Boaz

AU - Harmon, Cynthia

AU - Ross, Gregory A.

AU - Hendricks-Munoz, Karen

AU - Xu, Jie

AU - Black, Stephen M.

AU - Fineman, Jeffrey R.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Previous in vivo studies indicate that inhaled nitric oxide (NO) decreases nitric oxide synthase (NOS) activity and that this decrease is associated with significant increases in pulmonary vascular resistance (PVR) upon the acute withdrawal of inhaled NO (rebound pulmonary hypertension). In vitro studies suggest that superoxide and peroxynitrite production during inhaled NO therapy may mediate these effects, but in vivo data are lacking. The objective of this study was to determine the role of superoxide in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy in vivo. In control lambs, 24 h of inhaled NO (40 ppm) decreased NOS activity by 40% (P < 0.05) and increased endothelin-1 levels by 64% (P < 0.05). Withdrawal of NO resulted in an acute increase in PVR (60.7%, P < 0.05). Associated with these changes, superoxide and peroxynitrite levels increased more than twofold (P < 0.05) following 24 h of inhaled NO therapy. However, in lambs treated with polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) during inhaled NO therapy, there was no change in NOS activity, no increase in superoxide or peroxynitrite levels, and no increase in PVR upon the withdrawal of inhaled NO. In addition, endothelial NOS nitration was 18-fold higher (P < 0.05) in control lambs than in PEG-SOD-treated lambs following 24 h of inhaled NO. These data suggest that superoxide and peroxynitrite participate in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy. Reactive oxygen species scavenging may be a useful therapeutic strategy to ameliorate alterations in endogenous NO signaling during inhaled NO therapy.

AB - Previous in vivo studies indicate that inhaled nitric oxide (NO) decreases nitric oxide synthase (NOS) activity and that this decrease is associated with significant increases in pulmonary vascular resistance (PVR) upon the acute withdrawal of inhaled NO (rebound pulmonary hypertension). In vitro studies suggest that superoxide and peroxynitrite production during inhaled NO therapy may mediate these effects, but in vivo data are lacking. The objective of this study was to determine the role of superoxide in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy in vivo. In control lambs, 24 h of inhaled NO (40 ppm) decreased NOS activity by 40% (P < 0.05) and increased endothelin-1 levels by 64% (P < 0.05). Withdrawal of NO resulted in an acute increase in PVR (60.7%, P < 0.05). Associated with these changes, superoxide and peroxynitrite levels increased more than twofold (P < 0.05) following 24 h of inhaled NO therapy. However, in lambs treated with polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) during inhaled NO therapy, there was no change in NOS activity, no increase in superoxide or peroxynitrite levels, and no increase in PVR upon the withdrawal of inhaled NO. In addition, endothelial NOS nitration was 18-fold higher (P < 0.05) in control lambs than in PEG-SOD-treated lambs following 24 h of inhaled NO. These data suggest that superoxide and peroxynitrite participate in the decrease in NOS activity and rebound pulmonary hypertension associated with inhaled NO therapy. Reactive oxygen species scavenging may be a useful therapeutic strategy to ameliorate alterations in endogenous NO signaling during inhaled NO therapy.

KW - Nitric oxide synthase

KW - Reactive oxygen species

KW - Rebound pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=33644841823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644841823&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00019.2005

DO - 10.1152/ajplung.00019.2005

M3 - Article

VL - 290

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 2

ER -